Skip to Content
Merck
CN
  • Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.

Design, synthesis, and evaluation of bromo-retrochalcone derivatives as protein tyrosine phosphatase 1B inhibitors.

Bioorganic & medicinal chemistry letters (2011-05-11)
Zhiguo Liu, Woojung Lee, Su-Nam Kim, Goo Yoon, Seung Hoon Cheon
ABSTRACT

A series of bromo-retrochalcones was designed, synthesized and evaluated as PTP1B inhibitors based on licochalcone A and E. Compounds 6, 12, 13, 14, 25, 36, 37, 39, and 41 showed potent inhibitory effects against PTP1B, and compound 37, the most potent among the series, had an IC(50) value of 1.9 μM, about two-fold better than that of the positive control, ursolic acid.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Licochalcone A, ≥96.0% (HPLC)
Supelco
Ursolic acid, analytical standard
Sigma-Aldrich
Ursolic acid, ≥90%